From July 1, 2023 to September 14, 2023, the company has repurchased 261,000 shares, representing 0.06% for CNY 5.03 million. With this, the company has completed the repurchase of 1,426,700 shares, representing 0.33% for CNY 30.03 million under the buyback announced on April 25, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
12.35 CNY | -18.75% | -.--% | -45.40% |
May. 14 | China Grants Registration Approval for Antibacterial Drug | MT |
May. 06 | Hainan Poly Pharm Gets GMP Certificate From Saudi Authorities | MT |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-45.40% | 765M | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
-5.52% | 206B | |
+6.17% | 164B | |
-0.45% | 162B |
- Stock Market
- Equities
- 300630 Stock
- News Hainan Poly Pharm. Co., Ltd
- Tranche Update on Hainan Poly Pharm. Co., Ltd's Equity Buyback Plan announced on April 25, 2023.